After recovering from COVID-19, many individuals may experience long-term effects, including erectile dysfunction (ED). A recent study published in Scientific Reports found that 19% of 609 men surveyed continued to have ED, in some cases for up to two years after being hospitalized with COVID-19.
The COVID-19 Recovery Study II, conducted in 20 hospitals in Japan between March and September 2021, revealed that over half of the men who reported ED continued to experience it two years after their hospitalization. While some developed ED within 28 days of their COVID-19 infection, others experienced it two to five months later. Interestingly, the researchers did not find any specific factors such as COVID-19 severity, reinfection, vaccination frequency, or antiviral treatment that were associated with the likelihood of developing ED.
One possible explanation for the link between COVID-19 and ED is the damage to blood vessels caused by the virus. Severe acute respiratory syndrome coronavirus 2 can trigger the release of inflammatory cytokines and reduce oxygen levels in the blood, which can damage the vascular endothelium. Since erections rely on blood flow to the penis, any impairment in this process can lead to difficulties in achieving or maintaining an erection.
In addition to vascular damage, other long COVID symptoms such as fatigue, shortness of breath, anxiety, and sleep disturbances may also contribute to ED. The study found that individuals with ED had higher rates of these symptoms compared to those without ED. Moreover, feelings of anxiety and depression, as well as sleep disturbances, were more prevalent in individuals experiencing ED.
While ED may not be permanent in all cases, it is essential for healthcare providers to address this issue in post-COVID care. Treatment options for ED range from counseling and lifestyle changes to medications, devices, and surgery. By acknowledging the possibility of ED and providing appropriate support, individuals can still enjoy a fulfilling sex life after recovering from COVID-19.
Overall, the study highlights the importance of considering ED as a potential long-term effect of COVID-19 and incorporating support for this issue into post-acute care plans. By addressing ED and other long COVID symptoms, healthcare providers can help individuals navigate the physical and emotional challenges that may arise during their recovery journey.
